Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake

Thyroid

Volumn 22, Issue 6, 2012, Pages 611-616

  Kim, Hae Won ^a   Ahn, Byeong Cheol ^a   Lee, Sang Woo ^a   Lee, Jaetae ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; PERTECHNETIC ACID TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG UPTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASSAGE; PAROTID GLAND; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; RANDOMIZED CONTROLLED TRIAL; SALIVARY GLAND DISEASE;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MASSAGE; MIDDLE AGED; PAROTID GLAND; PROSPECTIVE STUDIES; RADIONUCLIDE IMAGING; SALIVARY GLANDS; SODIUM PERTECHNETATE TC 99M; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84861979577     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0188     Document Type: Article

References (31)

1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
2. De La Vieja A, Dohan O, Levy O, Carrasco N 2000 Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 80:1083-1105. (Pubitemid 30452012)
3. Mandel SJ, Mandel L 2003 Radioactive iodine and the salivary glands. Thyroid 13:265-271. (Pubitemid 36459308)
4. Grewal RK, Larson SM, Pentlow CE, Pentlow KS, Gonen M, Qualey R, Natbony L, Tuttle RM 2009 Salivary gland side effects commonly develop several weeks after initial radio-active iodine ablation. J Nucl Med 50:1605-1610.
5. Lin WY, Shen YY, Wang SJ 1996 Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med 21:780-782.
6. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napenas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bultzingslowen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT 2010 A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 18:1039-1060.
7. Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S 2005 Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med 46:261-266. (Pubitemid 43073433)
8. Liu B, Kuang A, Huang R, Zhao Z, Zeng Y, Wang J, Tian R 2010 Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial. J Nucl Med 51:618-623.
9. Van Nostrand D, Atkins F, Bandaru VV, Chennupati SP, Moreau S, Burman K, Wartofsky L 2009 Salivary gland protection with sialagogues: a case study. Thyroid 19:1005-1008.
10. Jeong SY, Lee J 2010 Radiation sialadenitis induced by high-dose radioactive iodine therapy. Nucl Med Mol Imaging. 44:102-109.
11. Wang S, Marchal F, Zou Z, Zhou J, Qi S 2009 Classification and management of chronic sialadenitis of the parotid gland. J Oral Rehabil 36:2-8.
12. Rice DH 1999 Chronic inflammatory disorders of the salivary glands. Otolaryngol Clin North Am 32:813-818. (Pubitemid 29489249)
13. Choi JW, Lee SS, Huh KH, Yi WJ, Heo MS, Choi SC 2009 The relationship between sialographic images and clinical symptoms of inflammatory parotid gland diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:e49-e56.
14. Caglar M, Tuncel M, Alpar R 2002 Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med 27:767-771. (Pubitemid 38295139)
15. Malpani BL, Samuel AM, Jaiswar RK 1998 Salivary gland scintigraphy after radioiodine therapy. Nucl Med Commun 19:183-184.
16. Jentzen W, Schneider E, Freudenberg L, Eising EG, Gorges R, Muller SP, Brandau W, Bockisch A 2006 Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer. Nucl Med Commun 27:669-676. (Pubitemid 44305307)
17. Konings AW, Coppes RP, Vissink A 2005 On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 62:1187-1194. (Pubitemid 40884434)
18. Hyer SL, Newbold K, Harmer CL 2010 Early and late toxicity of radioiodine therapy: detection and management. Endocr Pract 16:1064-1070.
19. Silberstein EB 2008 Reducing the incidence of 131I-induced sialadenitis: the role of pilocarpine. J Nucl Med 49:546-549. (Pubitemid 351520602)
20. Kita T, Yokoyama K, Higuchi T, Kinuya S, Taki J, Nakajima K, Michigishi T, Tonami N 2004 Multifactorial analysis on the short-term side effects occurring within 96 hours after radioiodine-131 therapy for differentiated thyroid carcinoma. Ann Nucl Med 18:345-349. (Pubitemid 39100103)
21. Walter MA, Turtschi CP, Schindler C, Minnig P, Muller-Brand J, Muller B 2007 The dental safety profile of high-dose radioiodine therapy for thyroid cancer: long-term results of a longitudinal cohort study. J Nucl Med 48:1620-1625. (Pubitemid 47572709)
22. Ma C, Xie J, Jiang Z, Wang G, Zuo S 2010 Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 37:1778-1785.
23. Van Nostrand D, Bandaru V, Chennupati S, Wexler J, Kulkarni K, Atkins F, Mete M, Gadwale G 2010 Radio-pharmacokinetics of radioiodine in the parotid glands after the administration of lemon juice. Thyroid 20:1113-1119.
24. Harden RM, Alexander WD, Shimmins J, Chisholm D 1969 A comparison between the gastric and salivary concentration of iodide, pertechnetate, and bromide in man. Gut 10:928-930.
25. Zuckier LS, Dohan O, Li Y, Chang CJ, Carrasco N, Dadachova E 2004 Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. J Nucl Med 45:500-507. (Pubitemid 47618627)
26. Klinger W, Correns H 1986 Action of different doses of I-131 on thyroid gland, its tissue distribution and elimination in adult male rats. Exp Clin Endocrinol 87:53-62. (Pubitemid 16071078)
27. Smith JJ, Croft BY, Brookeman VA, Teates CD 1990 Estimation of 24-hour thyroid uptake of I-131 sodium iodide using a 5-minute uptake of technetium-99m pertechnetate. Clin Nucl Med 15:80-83. (Pubitemid 20119686)
28. Umehara I, Yamada I, Murata Y, Takahashi Y, Okada N, Shibuya H 1999 Quantitative evaluation of salivary gland scintigraphy in Sjorgen's syndrome. J Nucl Med 40:64-69. (Pubitemid 29044174)
29. Vivino FB, Hermann GA 2008 Role of nuclear scintigraphy in the characterization and management of the salivary component of Sjogren's syndrome. Rheum Dis Clin North Am 34:973-986, ix.
30. Fogelman I, Cooke SG, Maisey MN 1986 The role of thyroid scanning in hyperthyroidism. Eur J Nucl Med 11:397-400. (Pubitemid 16143364)
31. Sahlmann CO, Siefker U, Lehmann K, Harms E, Conrad M, Meller J 2004 Quantitative thyroid scintigraphy for the differentiation of Graves' disease and hyperthyroid autoimmune thyroiditis. Nuklearmedizin 43:124-128. (Pubitemid 39121136)